"As a heterogenous disease that varies from patient to patient, ALS poses numerous challenges to clinicians seeking better treatments this leads to long delays in diagnosis because ALS can mimic other more common diseases. Additionally, the unpredictability in rate of progression makes treatment challenging. Our goal in working with Cloudmedx is to see if we can identify clinical features that will help us identify patients earlier and improve our ability to predict the course of their disease."